Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Alejandro Weinstein is a co-founder of WM Partners and has over 36 years of experience in the pharmaceutical industry. He was the CEO of CFR Pharmaceuticals S.A., transforming it into a global company before its sale to Abbott Laboratories. He holds investor and director roles in various ventures, including Olive Tree Ventures, an early-stage venture capital firm focused on health and enterprise in Israel. He also serves on the board of Israeli companies like Gauzy Ltd. and was appointed Chairman of the Board of Pluri Inc. in December 2025.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Automotive & Mobility Technologies1
Q&A
- What is Alexandre Weinstein's primary role and affiliation?
- Alexandre Weinstein is a member of the Board, a stakeholder in Cipia, and the founder of Olive Tree Ventures.
- Which sector does Alexandre Weinstein primarily focus on for investments?
- Alexandre Weinstein has a focus on the Automotive & Mobility Technologies sector, as evidenced by his investment in Cipia Vision.
- Can you name a notable portfolio company for Alexandre Weinstein?
- A notable portfolio company for Alexandre Weinstein is Cipia Vision, which provides AI-based monitoring solutions for drivers and passengers.
- What type of investment stage has Alexandre Weinstein participated in recently?
- Alexandre Weinstein participated in a PIPE funding stage in September 2022.
- What was Alexandre Weinstein's most recent investment activity?
- Alexandre Weinstein made an investment in September 2022.
- What is the business model of Cipia Vision, a company in Alexandre Weinstein's portfolio?
- Cipia Vision operates with a B2B business model, offering AI-based monitoring solutions.